![Safa'a Al-Rais](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Safa'a Al-Rais
Operationeel Directeur bij Resilience Biotechnologies, Inc.
Actieve functies van Safa'a Al-Rais
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Operationeel Directeur | - | - |
Loopbaan van Safa'a Al-Rais
Eerdere bekende functies van Safa'a Al-Rais
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Operationeel Directeur | 01-05-2009 | 01-10-2020 |
Statistieken
Internationaal
Canada | 3 |
Operationeel
Chief Operating Officer | 2 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |
- Beurs
- Insiders
- Safa'a Al-Rais
- Ervaring